Actively Recruiting
Siderophore-labelled Positron Emission Tomography for Correlating Invasive Fungal InfeCtions
Led by Peter MacCallum Cancer Centre, Australia · Updated on 2025-09-05
10
Participants Needed
1
Research Sites
173 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This trial will demonstrate localised uptake of a radiolabelled fungal component (siderophore) in areas of known specific invasive fungal (Aspergillus) infection.
CONDITIONS
Official Title
Siderophore-labelled Positron Emission Tomography for Correlating Invasive Fungal InfeCtions
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient has provided written informed consent
- Aged 18 years or older at written informed consent
- Within 2 weeks of proven or probable or possible invasive fungal infection (IFI) diagnosis as per EORTC criteria
- Imaging consistent with invasive pulmonary aspergillosis on CT or FDG-PET/CT with lesions at least 8mm in diameter
- Patient is willing and able to comply with the protocol for the duration of the study including scheduled visits such as follow up
You will not qualify if you...
- Women who are pregnant or lactating
- Iron infusion within one week prior to scan
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Peter MacCallum Cancer Centre
Melbourne, Victoria, Australia, 3000
Actively Recruiting
Research Team
A
Abby Douglas
CONTACT
B
Beatrice Sim
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here